Molecular genetics of malignant lymphoma

Reviews in Clinical and Experimental Hematology

Volumn 2, Issue , 1997, Pages 27-44

  Gaidano, Gianhica ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0013552291     PISSN: 11270020     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (80)

1. Harris NL, Jaffe ES, Stein H, et al. A Revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood, 84: 1361-1392, 1994.
2. Mitelman F. Catalog of chromosome aberrations in cancer. 4th edn. Wiley Liss, New York, 1991.
3. Gamberi B, Gaidano G, Parsa N, et al. Microsatellite instability is rare in B-cell non-Hodgkin's lymphomas. Blood, 89: 975-979, 1997.
4. Limpens J, de Jong D, van Krieken JHJM, et al. Bcl-2/JH rearrangements in benign lymphoid tissues with follicular hyperplasia. Oncogene, 6: 2271-2276, 1991.
5. Liu Y, Hcrnandez AM, Shibata D, et al. BCL2 translocations frequency rises with age in humans. Proc NatlAcad Sei USA, 991: 8910-8914, 1994.
6. Müller JR, Janz S, Goedert JJ, et al. Persistence of immunoglobulin heavy chain/c-myc recombination-positive lymphocyte clones in the blood of human immunodeficiency virus-infected homosexual men. Proc Natl Acad Sei USA, 92: 6577-6581, 1995.
7. Gaidano G, Ballerini P, Gong JZ, et al. p53 mutations in human lymphoid malignancies: Association with Burkitt lymphoma and chronic lymphocytic leukemia. Proc Natl Acad Sei USA, 88: 5413-5417, 1991.
8. Lo Coco F, Gaidano G, Louie DC, et al. p53 mutations are associated with histological transformation of follicular lymphoma. Blood, 82: 2289-2295, 1993.
9. Gaidano G, Hauptschein RS, Parsa NZ, et al. Deletions involving two distinct regions of 6q in Bcell non Hodgkin lymphoma. Blood, 80: 1781-1787, 1992.
10. Liu Y, Hermanson M, Grander D, et al. 13q deletions in lymphoid malignancies. Blood, 86: 1911-1915, 1995.
11. Kieff E and Leibowitz D. Oncogenesis by herpesvirus. In: Oncogenes and the molecular origin of cancer. Ed. Weinberg RA. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, pp. 259-280, 1989.
12. Chang Y, Cesarman E, Pessin MS, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science, 266: 1865-1869, 1994.
13. Cesarman E, Chang Y, Moore PS, et al. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. NEnglJAfed, 332: 1186-1191, 1995.
14. Gaidano G, Pastore C, Gloghini A, et al. Distribution of human herpesvirus-8 sequences throughout the spectrum of AIDS-related neoplasia. AIDS, 10: 941-949, 1996.
15. Chang Y, Moore PS, Talbot SJ, et al. Cyclin encoded by KS herpesvirus. Nature, 382: 410, 1996.
16. Moore PS, Boshoff C, Weiss RA, et al. Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV. Science, 274: 1739-1744, 1996.
17. Arvanitakis L, Geras-Raaka E, Gershengorn MC, et al. Kaposi's sarcoma-associated herpesvirus (KSHV-HHV 8) ORF 74 encodes a constitutively active G protein-coupled receptor that is expressed in Kaposi's sarcoma and primary effusion lymphoma. Blood 88 (suppl. 1): 205a, 1996.
18. Gaidano G, Newcomb E\V, Gong JZ, et al. Analysis of alterations pf oncogenes and tumor suppressor genes in chronic lymphocytic leukemia. AmJPatbol, 144: 1312-1319, 1994.
19. Offit K, Louie DC, Parsa NZ, et fil. Clinical and morphological features of B-cell small lymphocytic lymphoma with del(6) (q21q23). Blood, 83: 2611-2614, 1994.
20. lida S, Rao P, Nallasivam P, et al. The t(9;l4)(p!3;q32) chromosomal translocation associated with lymphoplasmacytoid lymphoma involves the PAX-5 gene. Blood, 88: 4110-4117, 1996.
21. Tsujimoto Y, Yunis J, Onorato-Showe L, et al. Molecular cloning of the chromosomal breakpoint on chromosome 11 in human B-cell neoplasms with the t(ll;14) chromosome translocation. Science, 224: 1403-1406, 1984.
22. Motokura T, Bloom T, Goo KH, et al. A novel cyclin encoded by a bcl-1 linked candidate oncogene. Nature, 350: 512-515, 1991.
23. Raffeld M and Jaffe ES. bcl-1, t(ll;l4), and mantle zone lymphomas. Blood, 78: 259-263, 1991.
24. de Boer CJ, Schuuring E, Dreef E, et al. Cyclin Dl protein analysis in the diagnosis of mantle cell lymphoma. Blood, 86: 2715-2723, 1995.
25. Berger F, Felman P, Sonet A, et al. Nonfollicular small B-cell lymphomas: A heterogeneous group of patients with distinct clinical features and outcome. Blood, 83: 2829-2835, 1994.
26. Bakshi A, Jensen JP, Goldman P, et al. Cloning the chromosomal breakpoint of t(l4;18) of human lymphomas: Clustering around JH on chromosome 14 and near a transcriptional unit on 18. Cell, 41: 889-906, 1985.
27. Tsujimoto Y, Finger LR, Yunis J, ct al. Cloning of the chromosome breakpoints of neoplastic B cells with the t(l4;18) chromosomal translocation. Science, 226: 1097-1099, 1984.
28. Cleary ML, Smith SD, Sklar J. Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl2/immunogIobulin transcript resulting from the t(l4;18) translocation. Cell, 47: 19-28, 1986.
29. Korsmeyer SJ. Bcl-2 initiates a new category of oncogenes: Regulators of cell death. Blood, 80: 879-886, 1992.
30. Hockenberry D, Nunez G, Milliman C, et al. Bcl-2 is an inner mitochondria! membrane protein that blocks programmed cell death. Nature, 348: 334-336, 1990.
31. Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell, 74: 609-619, 1993.
32. Zelenetz AD, Chen TT, Levy R. Clonal expansion in follicular lymphoma occurs subsequent to antigenic selection./ExpMed, 176: 1137-1148, 1992.
33. Reed JC, Stein C, Subasinghe C, et al. Antisense-mediated inhibition of bcl-2 protooncogene expression and leukemic cell growth and survival: Comparisons of phosphodiester and phosphorothioate oligodeoxynucleotides. Cancer Res, 50: 6565-6570, 1990.
34. McDonnel TJ, Deane N, Platt FM, et al. bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation. Cell, 57: 79-88, 1989.
35. Yano T, Jaffe ES, Longo DL, et al. MYC rearrangements in histologically progressed follicular lymphomas. Blood, 80: 758-767, 1992.
36. Ye BH, Lista F, Lo Coco F, et al. Alterations of BCL-6, a novel zinc-finger gene, in diffuse large cell lymphoma. Science, 262: 747-750, 1993.
37. Baron BW, Nucifora G, McNabe N, et al. Identification of the gene associated with the recurring chromosomal translocations t(3;l4)(q27;q32) and t(3;22)(q27;qll) in B-cell lymphomas. Proc NaÜ Acad Sei USA, 90: 5262-5266, 1993.
38. Kerckaert J-P, Deweindt C, Tilly H, et al. LAZ3, a novel zinc-finger encoding gene, is disrupted by recurring chromosome 3q27 translocations in human lymphoma. Nature Genet, 5: 66-70, 1993.
39. Cattoretti G, Chang C, Cechova K, et al. BCL-6 protein is expressed in germinal-center B cells. Blood, 86: 45-53, 1995.
40. Lo Coco F, Ye BH, Lista F, et al. Rearrangements of the BCL-6 gene in diffuse large-cell nonHodgkin lymphoma. Blood, 83: 1757-1759, 1994.
41. Ye BH, Chaganti S, Chang C-C, et al. Chromosomal translocations cause deregulated BCL6 expression by promoter substitution in B cell lymphoma. EMBOJ, 14: 6209-6217, 1995.
42. Volpe G, Vitolo U, Carbone A, et al. Molecular heterogeneity of B-lineage diffuse large cell lymphoma. Genes Chromosom Cancer, 16: 21-30, 1996.
43. Migliazza A, Martinotti S, Chen W, et al. Frequent somatic hypermutation of the 5' noncoding region of the BCL-6 gene in B-cell lymphoma. Proc Kail Acad Sei USA, 92: 12520-12524, 1995.
44. Gaidano G, Carbone A, Pastore C, et al. Frequent mutation of the 5' non-coding region of the BCL-6 gene in AIDS-related non-Hodgkin's lymphomas. Blood, in press, 1997.
45. Lee M-S, Blick MB, Pathak S, et al. The gene located at chromosome 18 band q21 is rearranged in uncultured diffuse lymphomas as well as follicular lymphomas. Blood, 70: 90-95, 1987.
46. Tang SC, Visser L, Hepperle B, et al. Clinical significance of bcl-2 MBR gene rearrangement and protein expression in diffuse large-cell non-Hodgkin lymphoma: An analysis of 83 cases. / Clin Oncol, 12: 149-154, 1994.
47. Offit K, Lo Coco F, Louie DC, et al. Rearrangements of the bcl-6 gene as a prognostic marker in diffuse large-cell lymhoma. NEnglJMed, 331: 74-80, 1994.
48. Houldsworth J, Mathew S, Rao P, et al. REL proto-oncogene is frequently amplified in extranodal diffuse large cell lymphoma. Blood, 87: 25-29, 1996.
49. Raghoebier S, Kramer MHH, van Krieken JHJM, et al. Essential differences in oncogene involvement between primary nodal and extranodal large cell lymphoma. Blood, 78: 2680-2685, 1991.
50. Dalla-Favera R. Chromosomal translocations involving the c-myc oncogene in lymphoid neoplasia. In: The causes and consequences of chromosomal aberrations. Ed. Kirsch IR. CRC Press, Boca Raton, FL, pp. 312-332, 1993.
51. Dalla-Favera R, Bregni M, EricksonJ, et al. Human c-myc oncogene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells. Proc NatI Acad Sei USA, 79: 7824-7827, 1982.
52. Dalla-Favera R, Martinotti S, Gallo RC, et al. Translocation and rearrangements of the c-myc oncogene in human undifferentiated B-cell lymphomas. Science, 219: 963-967, 1983.
53. Taub R, Kirsch I, Morton C. Translocation of c-myc gene into the immunoglobulin heavy chain locus in human Burkitt lymphoma and murine plasmacytoma cells. Proc Nail Acad Sei USA, 79: 7837-7841, 1982.
54. Davis M, Malcolm S, Rabbits TH. Chromosome translocations can occur on either side of the cmyc oncogene in Burkitt lymphoma cells. Nature, 30: 286-288, 1984.
55. Hollis GF, Mitchell KF, Battey J, et al. A variant translocation places the lambda immunoglobulin genes 3' to the c-myc oncogene in Burkitt's lymphoma. Nature, 307: 752-755, 1984.
56. Blackwood EM and Eisenman RN. Max: A helix-loop-helix zipper protein that forms a sequencespecific DNA-binding complex with Myc. Science, 251: 1211-1217, 1991.
57. Gu W, Cechova K, Tassi V, et al, Differential regulation of target gene expression by Myc/Max ratio. Pmc Natl Acacl Sei USA, 90: 2935-2939, 1993.
58. Cesarman E, Dalla-Favera R, Bentley D, el a!. Mutations in the first exon are associated with altered transcription of c-myc in Burkitt lymphoma. Science, 238: 1272-1275, 1987.
59. Bhatia K, Huppi K, Spangler G, et al. Point mutations in the c-MYC transactivation domain are common in Burkitt's lymphoma and mouse plasmacytoma. Nature Genêt, 5: 56-61, 1993.
60. Gu W, Bhatia K, Magrath IT, et al. Binding and suppression of the c-Myc transcriptional activation domain by p!07. Science, 264: 251-254, 1994.
61. Lombardi L, Newcomb E\V, Dalla-Favera R. Pathogenesis of Burkitt lymphoma: Expression of an activated c-myc oncogene causes thé tumorigenic conversion of EBV-infected human B lymphoblasts. Cell, 49: 161-170, 1987.
62. McManaway ME, Neckers LM, Loke SL, et al. Tumor-specific inhibition of lymphoma growth by an antisense oligodeoxy-nucleotide. Lancet, 335: 808-811, 1990.
63. Adams JM, Harris AW, Pinkert ÇA, et al. The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice. Nature, 318: 533-538, 1985.
64. Neri A, Barriga F, Inghirami G, et al. Epstein-Barr virus infection precedes clonal expansion in Burkitt's and acquired immunodeficiency-associated lymphoma. Blood, 77: 1092-1095, 1991-
65. Carbone A, Gloghini A, Vaccher E, et al. Kaposi's sarcoma-associated herpesvirus DNA séquences in AIDS-related and AIDS-unrelated lymphomatous effusions. BrJ Haematol, 94: 533-543, 1996.
66. Carbone A and Gaidano G. HHV-8 positive body cavity-based lymphoma: A novel lymphoma entity. BrJ Haematol, in press, 1997.
67. Jaffe ES. Primary body-cavity-based AIDS-related lymphomas: Evolution of a new disease entity. Am] Clin Patbol, 105: 141-143, 1996.
68. Nador RG, Cesarman E, Chadburn A, et al. Primary effusion lymphoma: A distinct clinicopathological entity associated with Kaposi's sarcoma-associated herpesvirus. Blood, 88: 645-656, 1996.
69. Gaidano G and Dalla-Favera R. Molecular pathogenesis of AIDS-related lymphomas. Adv Cancer Res, 67: 113-153, 1995.
70. Gaidano G and Carbone A. AIDS-related lymphomas: From pathogenesis to pathology. BrJ Haematol, 90: 235-243, 1995.
71. Ballerini P, Gaidano G, Gong JZ, et al. Multiple genetic lesions in acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma. Blood, 81: 166-176, 1993.
72. Pelicci P-G, Knowles DM, II, Arlin ZA, et al. Multiple monoclonal B cell expansions and c-myc oncogene rearrangements in acquired immunodeficiency syndrome-related lymphoproliferative disorders. Implications for lymphomagenesis.J.Exp.A//, 164: 2049-2076, 1986.
73. Gaidano G, Lo Coco F, Ye BH, et al. Rearrangements of the BCL-6 gene in acquired immunodeficiency syndrome-associated non-Hodgkin's lymphoma: Association with diffuse large-cell subtype. Blood, 84: 397-102, 1994.
74. Carbone A, Gaidano G, Gloghini A, et al. BCL-6 protein expression in AIDS-related nonHodgkin's lymphomas. Inverse relationship with Epstein-Barr virus-encoded latent membrane protein-1 expression. AmJPathol, 150: 155-165, 1997.
75. Gaidano G, Capello D, Pastore C, et al. Analysis of HHV-8 infection in AIDS-related and AIDSunrelated primary central nervous system lymphoma. JInfect Dis, in press, 1997.
76. Morris SV, Kirstein MN, Valentine MB, et al. Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. Science, 263: 1281-1284, 1994.
77. Lamant L, Meggetto F, al Saati T, et al. High incidence of the t(2;5) (p23;q35) translocation in anaplastic large cell lymphoma and its lack of detection in Hodgkin's disease. Comparison of cytogenetic analysis, reverse transcriptase-polymerase chain reaction, and p-80 immunostaining. Blood, 87: 284-291, 1996.
78. Lee MS, Chang KS, Cabanillas F, et al. Detection of minimal residual cells carrying the t(l4;18) by DNA sequencing amplification. Science, 237: 175-178, 1987.
79. Rimokh R, Berger F, Delsol G, et al. Detection of the chromosomal translocation t(ll;l4) by polymerase chain reaction in mantle cell lymphomas. Blood, 83: 1871-1875, 1994.
80. Magrath IT. Prospects for the therapeutic use of antisense oligonucleotides in malignant lymphomas. Annals Oncol, 5: S67-S70, 1994.